#830 – The Industry Wire

August 28, 2026 Brian Casey 0 min read
  1. CMS cracks down on $1.6B in lab fraud payments. 
  2. FDA approves four new COVID-19 vaccines for 2026-2027. 
  3. FDA approves heart/stroke indications for Lilly’s Mounjaro. 
  4. Study tracks on-again, off-again Wegovy use.
  5. AstraZeneca releases autopsy on failed heart disease drug.
  6. Sanford acquisition of Memorial health clears state hurdle. 
  7. High costs push Americans abroad for fertility treatments.
  8. Former CDC staffers detail how to fix agency. 
  9. Florida AG sues PBMs for alleged drug price fixing.
  10. Physician specialists push back on No Surprises study.
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Lung Cancer Screening September 17, 2026

Expanding CT Lung Screening at WCLC 2026 September 17, 2026

Presentations at this week’s WCLC 2026 discussed how to make low-dose CT lung cancer screening available to as many eligible people as possible.

Artificial Intelligence September 14, 2026

Top 10 AI Vendors by FDA Approvals September 14, 2026

Radiology maintained its lead in FDA approvals for AI-enabled medical devices in new data released by the agency.

Artificial Intelligence September 10, 2026

Harrison’s Teleradiology Play September 10, 2026

AI developer Harrison.ai is expanding its business model by supporting a teleradiology venture called Frontier Radiology that’s scaling up and hiring radiologists.